Genenta Science S.p.A. (GNTA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 25M |
| Enterprise Value | 27.07M |
| P/E Ratio | -5.09 |
| PEG Ratio | -0.15 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.63 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.2 |
| Return On Equity | -0.37 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -26,973 |
| EBITDA | -5.86M |
| Net Income | -6.27M |
| Diluted EPS | -0.33 |
| Total Cash | 28.15M |
| Total Cash/Share | 1.33 |
| Total Debt | 7.6M |
| Total Debt/Equity | 0.35 |
| Current Ratio | 14.16 |
| Book Value Per Share | 1.03 |
| 52-Week Change | -37.25 |
| 52-Week High | 10 |
| 52-Week Low | 0.55 |
| Moving Average 50 Days | 1.01 |
| Moving Average 200 Days | 1.65 |
| Average Volume | 1.45M |
| Shares Outstanding | 19.15M |
| % Held by Institutions | 5.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |